Peer-reviewed veterinary case report
Survival and recurrence after surgery for skin haemangiosarcoma in 94
By Szivek, A et al.·Published in Veterinary and comparative oncology·2012·William R. Prichard Veterinary Medical Teaching Hospital, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*.
- Species:
- dog
Plain-English summary
A study looked at 94 dogs diagnosed with skin tumors called dermal hemangiosarcoma (HSA) to see how well they did after surgery. The average survival time for these dogs was about 987 days, which is quite good. However, many dogs (77%) had their tumors come back after treatment, especially if they were from breeds known to be at risk and had tumors in certain locations. Dogs with tumors caused by sun exposure tended to live longer, while those with more aggressive tumors had a higher chance of spreading to other parts of the body.
People also search for: dog skin tumor treatment · hemangiosarcoma prognosis in dogs · dog cancer survival rates
Abstract
Canine dermal haemangiosarcoma (HSA) is believed to have a better prognosis compared to HSA in other organs, but outcome has only been reported in a small number of dogs. The purpose of this study was to assess outcome and prognostic factors in a larger cohort of dogs with dermal HSA. Clinical data was collected retrospectively for 94 dogs and histopathology was reviewed in 53 dogs. Median overall survival time was 987 days. Dogs of predisposed breed with ventral location and histologic solar changes had longer survivals. Loco-regional recurrence occurred in 72/94 (77%) dogs. Predisposed breeds with ventral location and multiple masses were more likely to develop recurrence. Non-predisposed breeds with invasive tumours were more likely to develop metastasis. Results suggest that dogs with solar-induced dermal HSA may have high recurrence rates, but prolonged survivals. Dogs with non-solar tumours may be at increased risk for metastasis and shorter survival.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/22236371/